Bouchta, N B <br/><br/>
Conversion from tacrolimus to cyclosporin is associated with a significant improvement of glucose metabolism in patients with new-onset diabetes mellitus after renal transplantation.  [electronic resource] 

 -  Transplantation proceedings  May 2005 
 - 1857-60 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0041-1345 
<br/><br/><label>Standard No.: </label>10.1016/j.transproceed.2005.03.137  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Blood Glucose--drug effects<br/>Cyclosporine--therapeutic use<br/>Diabetes Mellitus--blood<br/>Female<br/>Glycated Hemoglobin--metabolism<br/>Humans<br/>Hypoglycemic Agents--therapeutic use<br/>Immunosuppressive Agents--adverse effects<br/>Incidence<br/>Insulin--therapeutic use<br/>Kidney Transplantation--adverse effects<br/>Male<br/>Middle Aged<br/>Postoperative Complications--blood<br/>Reoperation--statistics & numerical data<br/>Retrospective Studies<br/>Tacrolimus--adverse effects